Valink Therapeutics
Discovering bispecific antibody drug-conjugates (BsADC) against cancer Status: Active. Batch: YC Winter 2021. HQ: Boston, MA, USA. Industry: Healthcare. https://www.valinktx.com/
Details
- city
- Boston
- cohort year
- 2021
- country
- United States
- exited
- false
- industry
- healthcare
- one liner
- Discovering bispecific antibody drug-conjugates (BsADC) against cancer
- status
- active
- team size
- 15
accelerator → invested in1
participated in → cohort1